Delivery Order SPE2DB22D2206-SPE2DB24FHC35
Award Date 5/9/24
Potential Completion Date 5/10/24
Potential Value $2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order valued at $2,241.90 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for medical products, including "INJECTOR DRG DLV BD PHASEAL IV LL N35 LF", with a completion date of January 16, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
- This federal contract award is for the delivery of Activase 50 mg vials to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,864.71, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. The IDC, valued up to $999,999,999.00 through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,693.19 Delivery Order, which is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, covers the supply of 4562764849 ! ABRYSVO VIAL WITH DILUENTS, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion...
- This federal contract award, valued at $223,185.69, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award is a delivery order (SPE2DB22D3501|SPE2DB25FTR32) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,254.70, is for the supply of ACTIVASE 100 MG VIALS, a medical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which...
- This federal contract award is a delivery order valued at $1,068.48, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the delivery of pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes treatments, neurological medications, pain management pharmaceuticals, hormone treatments, antibiotics, and specialized medical supplies. This delivery order is part of a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor. The $1,016.82 Delivery Order contract is a Firm Fixed Price arrangement to provide Repatha 140 mg/ml SureClick syringes to the DLA. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to deliver a wide range of pharmaceutical products and...
- This federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order valued at $5,287.68 and awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and a completion date of December 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle...
- This federal contract award, valued at $28,113.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Epinephrine 1 mg/ml ampules. The contract is a Delivery Order valued at $1,362.20 with a firm fixed price and a completion date of July 15, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FHC35Delivery Order
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $1,989.00 for the provision of 4564552749 - EPTIFIBATIDE 75 MG/100 ML VIAL 100ML. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the world's largest pharmaceutical distribution companies. This Delivery Order is placed under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 8/8/24, 9:13 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 5/9/24 |